about
IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channelsSecretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cellsInternational Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligandsGuideToPharmacology.org--an updateInternational Union of Pharmacology. LXXII. Recommendations for trace amine receptor nomenclatureEmerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin SIs urotensin-II the new endothelin?Neuropeptide B and W: neurotransmitters in an emerging G-protein-coupled receptor systemEndothelinApelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular systemEndothelin receptors and their antagonistsThe IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligandsInternational Union of Pharmacology. XXIX. Update on endothelin receptor nomenclatureEndothelin@25 - new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12Emerging roles of apelin in biology and medicineInternational Union of Pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and functionExpression and vasoconstrictor function of anorexigenic peptides neuromedin U-25 and S in the human cardiovascular systemImmunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cellsVasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitroThromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan[125I]-PD151242: a selective radioligand for human ETA receptorsCharacterization of the binding of endothelin ETB selective ligands in human and rat heartCharacterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissuesThe Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptorsNo evidence for a local renin-angiotensin system in liver mitochondriaThe IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligandsElabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial HypertensionIUPHAR-DB: updated database content and new featuresThe Concise Guide to PHARMACOLOGY 2013/14: overview.The Concise Guide to PHARMACOLOGY 2015/16: OverviewIdentifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography.18F-Fluoride and 18F-Fluorodeoxyglucose Positron Emission Tomography After Transient Ischemic Attack or Minor Ischemic Stroke: Case-Control Study.Evidence using immunoelectron microscopy for regulated and constitutive pathways in the transport and release of endothelin.Secretory pathways in endothelin synthesis.Inotropic action of the puberty hormone kisspeptin in rat, mouse and human: cardiovascular distribution and characteristics of the kisspeptin receptorModulation of the apelin/APJ system in heart failure and atherosclerosis in manImaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function.Cellular localization of receptors using antibodies visualized by light and dual labeling confocal microscopy.Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.
P50
Q24259024-7BAA7725-8FA3-4242-9064-D7BB51E42D4DQ24552364-C6A77965-25AD-4F11-9654-ED1C2AE541F4Q24605072-EEAC9774-2181-4F0E-B2F0-F496CBA5FAE0Q24618882-B0F34C38-32A4-4ADA-80A5-C755C29953E6Q24634650-F7763AFF-0BE4-42D5-B8EA-0CE2D58E230FQ24656469-D9BE399C-485D-4C24-AF1C-8A6FCCDE5AF0Q24672927-FF3A0A8B-8741-4029-8BC9-4812583EB956Q24675462-AD9F1FBD-DF4C-4135-9597-9F76B0EE86BEQ26767156-4375B6CA-BE4C-4376-9F5D-A54E5AA59C73Q26823618-CD6BA340-ECF0-4FB7-A240-A9A11A36B366Q27023208-D45776B1-5959-46FD-809E-FD89445B454CQ27136827-0979D0E4-B337-47B8-AFAF-6372423AA701Q28201563-D8145D70-CE07-4759-9886-6684FE8FDB5BQ28246158-3E1D2202-7CF9-48CD-A273-94F2E2695B4AQ28252002-5BF4EFEA-053E-4583-BA34-32B1046666DAQ28289212-7311EEF2-04CD-4A24-AB7A-8EFC7ABA57EAQ28299911-C72AA9CF-F794-4371-81CF-5E08D68A4755Q28303724-2A309151-B4B0-4E30-B47E-38D9E55758B5Q28363807-332706C7-5289-4655-B0E2-01E56AC12B34Q28365334-15E8F976-C39D-4143-AD1B-BCA462AAF23EQ28369196-C261104F-C0E5-4D0B-80F4-8412D2098190Q28379280-497E07F2-02F8-4D30-A875-DCF096A73DE6Q28379363-1F950602-BD6B-42BF-BA0B-2FCFC51F746EQ28552564-DE72737A-18D9-4540-BC12-ABA502F83AEAQ28569802-7C34F89D-26E7-438B-85AF-4436BB383B00Q28603128-3F761CF4-6A95-4785-9AA2-7D05E0E8DD99Q30032666-251B9AE1-D474-498E-AA1C-0D14B44FD1FBQ30485756-F2F3D295-C61F-4D34-AF34-0146FA7AEDF1Q30486728-30057098-4CE4-4C65-BA64-A52416285509Q30488640-9876C74F-3872-4D59-82D5-EC6DCCCAF576Q30658182-F1FA4FC6-2F82-49C9-9A4B-78569624E676Q30842993-2EA5E837-52FE-4F9F-AF4D-9E39145535DDQ32085118-24D466B7-456A-4696-8A46-471FC45C8A73Q33541209-2F60FBF4-31F1-4573-82B5-14CD7D6810BEQ34087759-0E36F576-5356-423F-99D2-30A3B1FBA12DQ34116830-ADB1AB36-9A36-4D88-8C2B-7B9F113841F6Q34132798-405CD95E-D90D-46E7-A53B-0799D6CD9D52Q34149940-086496AB-A696-4EF7-AC65-84120163E8E6Q34295085-25331262-B1FA-4550-AD83-4A9D42FBD41CQ34361662-8A52806F-F152-40C6-96FD-90262BED1B8A
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Anthony P Davenport
@ast
Anthony P Davenport
@en
Anthony P Davenport
@es
Anthony P Davenport
@nl
type
label
Anthony P Davenport
@ast
Anthony P Davenport
@en
Anthony P Davenport
@es
Anthony P Davenport
@nl
altLabel
Anthony Peter Davenport
@en
prefLabel
Anthony P Davenport
@ast
Anthony P Davenport
@en
Anthony P Davenport
@es
Anthony P Davenport
@nl
P1006
P214
P244
P1006
P1053
A-5773-2008
P106
P1153
35271461400
P21
P214
P244
n2002134584
P2456
P31
P3829
P496
0000-0002-2096-3117
P734
P735
P7859
lccn-n2002134584